×
About 3,896 results

ALLMedicine™ Anaplastic Large Cell Lymphoma Center

Research & Reviews  1,835 results

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
https://doi.org/10.1093/asj/sjab177
Aesthetic Surgery Journal; Ha M, Ngaage LM et. al.

Apr 15th, 2021 - Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a locally aggressive T-cell lymphoma that can develop following breast implantation. In 2017, and updated in 2019, the National Comprehensive Cancer Network (NCCN) recommended ...

A National Survey to Assess the Population's Perception of Breast Implant-Associated An...
https://doi.org/10.1097/PRS.0000000000007700
Plastic and Reconstructive Surgery; Azzi AJ, Almadani Y et. al.

Mar 29th, 2021 - The goal of this study was to gauge the public's general perception of breast implants, levels of concern, spontaneous word associations, and misperceptions that might need to be addressed by plastic surgeons regarding breast implant-associated an...

Discussion: A National Survey to Assess the Population's Perception of Breast Implant-A...
https://doi.org/10.1097/PRS.0000000000007701
Plastic and Reconstructive Surgery; Chi D, Ha AY et. al.

Mar 29th, 2021 - Discussion: A National Survey to Assess the Population's Perception of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Breast Implant Illness.|2021|Chi D,Ha AY,Keane G,Myckatyn TM,|

see more →

Guidelines  5 results

Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anap...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106983
Journal of Clinical Oncology : Official Journal of the Am... Jaffe ES, Ashar BS et. al.

Feb 11th, 2020 - To provide guidelines for the accurate pathologic diagnosis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the patient with suspected BIA-ALCL, and the pathologic evaluation of the capsulecto...

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) - Letter to Health Care Providers
https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/ucm630863.htm
FDA

Feb 5th, 2019 - The Food and Drug Administration (FDA) wants to increase awareness about an association between all breast implants, regardless of filling or texture, and Breast Implant Associated- Anaplastic Large Cell Lymphoma (BIA-ALCL). The FDA received repor...

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
https://academic.oup.com/asj/article/39/Supplement_1/S14/5304915
Oishi,N.,et al

Jan 30th, 2019 - Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a newly included provisional entity in the 2016 revision of the World Health Organization classification, is a distinct form of CD30-positive T-cell non-Hodgkin lymphoma that ari...

2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
https://academic.oup.com/asj/article/39/Supplement_1/S3/5304919
Clemens,M.,et al

Jan 30th, 2019 - National Comprehensive Cancer Network (NCCN) guidelines represent the consensus standard of care for diagnosis and management of the majority of known cancers. NCCN guidelines on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) ...

NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated...
https://doi.org/10.1093/asj/sjw259
Aesthetic Surgery Journal; Clemens MW, Horwitz SM

Feb 11th, 2017 - Published case series demonstrate a lack of treatment standardization for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) with a wide variety of therapeutic strategies being employed at all stages of disease. The National Compr...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  1,953 results

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
https://doi.org/10.1093/asj/sjab177
Aesthetic Surgery Journal; Ha M, Ngaage LM et. al.

Apr 15th, 2021 - Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a locally aggressive T-cell lymphoma that can develop following breast implantation. In 2017, and updated in 2019, the National Comprehensive Cancer Network (NCCN) recommended ...

A National Survey to Assess the Population's Perception of Breast Implant-Associated An...
https://doi.org/10.1097/PRS.0000000000007700
Plastic and Reconstructive Surgery; Azzi AJ, Almadani Y et. al.

Mar 29th, 2021 - The goal of this study was to gauge the public's general perception of breast implants, levels of concern, spontaneous word associations, and misperceptions that might need to be addressed by plastic surgeons regarding breast implant-associated an...

Discussion: A National Survey to Assess the Population's Perception of Breast Implant-A...
https://doi.org/10.1097/PRS.0000000000007701
Plastic and Reconstructive Surgery; Chi D, Ha AY et. al.

Mar 29th, 2021 - Discussion: A National Survey to Assess the Population's Perception of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Breast Implant Illness.|2021|Chi D,Ha AY,Keane G,Myckatyn TM,|

see more →

News  101 results

NICE: Brentuximab Vedotin for Untreated sALCL
https://www.staging.medscape.com/viewarticle/933703

Jul 9th, 2020 - The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending brentuximab vedotin (Adcetris, Takeda) with cyclophosphamide, doxorubicin, and prednisone (CHP) for untreated systemic anaplastic large ce...

NICE: Brentuximab Vedotin for Untreated sALCL
https://www.medscape.com/viewarticle/933703

Jul 9th, 2020 - The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending brentuximab vedotin (Adcetris, Takeda) with cyclophosphamide, doxorubicin, and prednisone (CHP) for untreated systemic anaplastic large ce...

Number of Cases of Breast Implant-linked Lymphoma in the UK
https://www.medscape.com/viewarticle/933637

Jul 8th, 2020 - As of April 2020, there have been 68 cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reported in the UK. This figure includes cases where the original implantation did not occur in the UK. Based on the number of cases,...

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) - Letter to Health Care Providers | FDA
https://www.fda.gov/medical-devices/letters-health-care-providers/breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl-letter-health-care-providers

The information in this letter has been superseded by The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from the Market: FDA Sa...

Breast Implant and Blood Cancer Advice Updated
https://www.medscape.com/viewarticle/899959

Aug 21st, 2019 - Health professionals have been reminded to continue to report suspected cases of breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) in patients who have had breast implants or who have had them removed. In an update to two previou...

see more →